BRS questions Congress on Manakin Bio, Yentra Tech investments, cites lack of financial credibility
Congress government had been making dubious investment announcements involving companies such as Godi India, Swachh Bio, Walsh Karra, and Ursa, says Krishank.
Hyderabad: Exposing what he termed as the false claims of the Congress government, BRS spokesperson M Krishank on Tuesday alleged that yet another fraudulent investment announcement was made to mislead the people of Telangana.
In a statement, Krishank said the company Manakin Bio was not even registered with the Ministry of Corporate Affairs and had launched a “fraudulent” website lacking specific details on March 16, 2025. He questioned how such a company, with no transparent financials, could announce an investment of Rs. 340 crore in Telangana.
Citing another example, Krishank said Yentra Tech Controls had announced an investment of Rs. 255 crore, while its 2024 Annual Financial Statement showed it had incurred a loss of Rs. 2,34,950. “How can such a company invest Rs. 255 crore?” he asked.
“We will take up these issues with the Ministry of Corporate Affairs to question how the Congress government has been announcing investments through suspicious companies,” Krishank said.
He further alleged that since coming to power, the Congress government had been making dubious investment announcements involving companies such as Godi India, Swachh Bio, Walsh Karra, and Ursa.
